RTP Mobile Logo

PARP Inhibition in the Management of Prostate Cancer — Where We Are and Where We’re Headed (Faculty Presentations)

Johann S de Bono, MB ChB, MSc, PhD, FMedSci
Regius Professor of Cancer Research
Professor of Experimental Cancer Medicine and Honorary Consultant in Medical Oncology
Head of Clinical Studies Division
Director of Drug Development Unit 
Head of the Prostate Cancer Targeted Therapy Group
The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust
London, United Kingdom

Fred Saad, MD
Professor and Chief of Urology
Director of GU Oncology
Raymond Garneau Chair in Prostate Cancer
University of Montreal Hospital Center (CHUM)
Director, Prostate Cancer Research
Montreal Cancer Institute/CRCHUM
Montréal, Québec, Canada

PowerPoint slides